1 Min Read
April 13 (Reuters) - Gemphire Therapeutics Inc:
* Gemphire Therapeutics files for resale of up to 2.3 million shares of co's common stock by selling stockholders - sec filing Source text - bit.ly/2p1yMht Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.